Peter,
Do you still watch CDIC? I am watching very closely now.
>>>>SAN DIEGO, Nov 13, 2001 /PRNewswire via COMTEX/ -- CardioDynamics International Corporation (Nasdaq: CDIC chart, msgs), the innovator and market leader of Impedance Cardiography (ICG) technology and manufacturer of BioZ(R) noninvasive digital cardiac function monitoring systems, today announced that the American Medical Association (AMA) has issued a Current Procedural Terminology (CPT) code for its ICG technology. The new CPT code, 93701, is specific for the Company's ICG technology and may be used alone or in conjunction with other diagnostic cardiovascular tests when submitting for reimbursement of claims to either Medicare or private insurers. The new CPT code was published in the Federal Register, is included in Medicare's 2002 database, and becomes effective January 1, 2002.
According to the AMA, healthcare providers use the CPT code when reporting medical procedures and services under public and private health insurance programs, and for administrative management in claims processing and developing guidelines for medical care review. Previously, healthcare providers utilized generic codes for private insurance and a lower level code for Medicare. The newly issued CPT code will simplify billing procedures for the medical community.
"We are very pleased to receive our own unique CPT Code for our ICG technology, stated Michael K. Perry, CardioDynamics' Chief Executive Officer. "Receipt of this code from the AMA reflects our technology's acceptance and importance as a key tool to the medical community. Our CPT code now allows customers to perform BioZ monitoring with the knowledge that the reimbursement filing and payment has been standardized."
Perry added, "The CPT code is another step toward facilitating market penetration and broad clinical use of our technology and ultimately establishing Impedance Cardiography as a standard of care for a broad range of patients, including those with congestive heart failure and high blood pressure."
The Company also announced that it is exhibiting its BioZ ICG technology at the American Heart Association 2001 Scientific Sessions in Anaheim, California being held November 12-14, 2001. With an estimated 5,000 cardiologists in attendance, it is an excellent opportunity for the Company to obtain sales and sales leads and also highlight the year's product development and clinical application progress.<<
snip
Cheers, Tuck |
